Preview

Pacific Medical Journal

Advanced search

Usage of 5-fluorouracil to prevent excessive scarring after hypotensive operations of non-penetrating type

https://doi.org/10.17238/PmJ1609-1175.2018.2.52-54

Abstract

Objective. The effectiveness of topical application of 5-fluorouracil after antiglaucoma operations for the prevention of scarring of the formed outflow pathways of the intraocular fluid was analyzed. Methods. The study included 112 patients over 35 y.o. (125 eyes), operated for the primary open-angle glaucoma in the far-advanced stage in PCEM in 2015-2017. Patients were divided into two groups comparable in age, glaucoma stage, and pre-operation level of intraocular pressure (IOP): 1st group - 57 patients (63 eyes) were undergone non-penetrating deep sclerectomy with 5 % 5-fluorouracil; 2nd group - 55 patients (62 eyes) without 5-fluorouracil. Results. On the 7th day after the operation there was the difference in IOP values between groups: when using antimetabolite they were significantly lower. On the 15th day the difference in values significantly increased, and this tendency persisted for six months. By the 9th months of observation average values of IOP in both groups was almost equal. In a year and a half there were two patients who did not need a laser descemetopuncture from the group used 5-fluorouracil, there were no such patients in the 2nd group. Conclusions. Thus, the use of 5-fluorouracil in the form of injections is a safe way of preventing early scarring processes in the area of formed outflow pathways of the eye fluid, which significantly increases the effectiveness of antiglaucoma surgery.

About the Authors

G. A. Fedyashev
Pacific State Medical University; Primorskiy Center of Eye Microsurgery
Russian Federation


P. V. Shellenberg
Pacific State Medical University
Russian Federation


E. V. Eliseeva
Pacific State Medical University
Russian Federation


References

1. Куроедов А.В., Брежнев А.Ю., Александров А.С., Огородникова В.Ю. Принципы лечения начальной стадии глаукомы: хирургия против терапии (обзор литературы) // Военномедицинский журнал. 2011. Т. 332, № 5. С. 28-35

2. Петров С.Ю. Современная концепция борьбы с избыточным рубцеванием после фистулизирующей антиглаукомной операции. Факторы риска и антиметаболические препараты // Офтальмология. 2017. Т. 14, № 1. С. 5-11

3. Петров С.Ю. Современная концепция борьбы с избыточным рубцеванием после фистулизирующей хирургии глаукомы. Противовоспалительные препараты и новые тенденции // Офтальмология. 2017. Т. 14, № 2. С. 99-105

4. Петров С.Ю., Антонов А.А., Вострухин С.В. [и др.]. Активация фильтрационной подушки в раннем периоде после фистулизирующей операции // Офтальмология. 2014. Т. 11, № 3. С. 80-88

5. Петров С.Ю., Сафонова Д.М. Современная концепция избыточного рубцевания в хирургии глаукомы // Офтальмология. 2015. Т. 12, № 4. С. 9-16

6. Христин М., Еричев В. П., Анисимова С.Ю. [и др.]. Комбинированная система профилактики избыточного рубцевания в хирургии глаукомы // Глаукома. 2010. № 2. С. 16-18

7. Amoozgar B, Lin S.C., Han Y., Kuo J. A role for antimetabolites in glaucoma tube surgery: current evidence and future directions // Curr. Opin. Ophthalmol. 2016. Vol. 27, No. 2. P. 164-169.

8. Mercieca K., Drury B., Bhargava A., Fenerty C. Trabeculectomy bleb needling and antimetabolite administration practices in the UK: A glaucomaspecialist national survey // Br. J. Ophthalmol. 2017. doi: 10.1136/bjophthalmol-2017-310812.

9. Lindemann F., Plange N., Kuerten D. [et al.]. Three-year follow-up of trabeculectomy with 5-fluorouracil // Ophthalmic Res. 2017. Vol. 58, No. 2. P. 74-80.

10. Wong M.H., Husain R., Ang B.C. [et al.]. The Singapore 5-fluorouracil trial: Intraocular pressure outcomes at 8 years // Ophthalmology. 2013. Vol. 120, No. 6. P. 1127-1134


Review

For citations:


Fedyashev G.A., Shellenberg P.V., Eliseeva E.V. Usage of 5-fluorouracil to prevent excessive scarring after hypotensive operations of non-penetrating type. Pacific Medical Journal. 2018;(2):52-54. (In Russ.) https://doi.org/10.17238/PmJ1609-1175.2018.2.52-54

Views: 350


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1609-1175 (Print)